New hope for Parkinson's patients struggling with debilitating constipation
NCT ID NCT05603715
Summary
This study is testing whether a medication called pyridostigmine can safely and effectively treat chronic constipation in people with Parkinson's disease. Sixteen participants with Parkinson's and significant constipation will take the medication for several weeks while tracking their bowel movements and symptoms. Researchers aim to find a new treatment option for this common and distressing problem that greatly affects quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Vermont Medical Center
RECRUITINGBurlington, Vermont, 05401, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.